| dbo:abstract | - Prasterone enanthate, also known as dehydroepiandrosterone enanthate (DHEA-E) and sold in combination with estradiol valerate under the brand name Gynodian Depot among others, is a weak androgen, estrogen, and neurosteroid medication which is used as a component of menopausal hormone therapy to treat menopausal symptoms in women. It is available only as an injectable preparation in combination with estradiol valerate. The medication is given by injection into muscle typically once every 4 weeks. Prasterone enanthate is a synthetic androgen, estrogen, and neurosteroid. It is a steroid ester and a long-lasting prodrug of prasterone (dehydroepiandrosterone; DHEA) in the body. Prasterone is a naturally occurring prohormone of androgens and estrogens and hence is an agonist of the androgen and estrogen receptors, the respective biological targets of androgens like testosterone and estrogens like estradiol. Prasterone also has a variety of activities of its own, including neurosteroid and other activities. An injection of prasterone enanthate has a duration of action in terms of elevated prasterone levels of about 18 days. The combination of estradiol valerate and prasterone enanthate was developed as early as 1966 and was introduced for medical use in 1975. The formulation is marketed widely throughout Europe, and is also available in several Latin American countries and in Egypt. It is not available in any predominantly English-speaking countries. (en)
|
| dbo:alternativeName | - Withestradiol valerate: Gynodian Depot, others (en)
|
| dbo:atcCode | |
| dbo:casNumber | |
| dbo:class | |
| dbo:drugbank | |
| dbo:fdaUniiCode | |
| dbo:pubchem | |
| dbo:thumbnail | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID | |
| dbo:wikiPageLength | - 22823 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID | |
| dbo:wikiPageWikiLink | |
| dbp:atcPrefix | |
| dbp:atcSuffix | |
| dbp:atcSupplemental | |
| dbp:bioavailability | |
| dbp:c | |
| dbp:casNumber | |
| dbp:chemspiderid | |
| dbp:class | |
| dbp:drugbank | |
| dbp:durationOfAction | |
| dbp:eliminationHalfLife | |
| dbp:excretion | |
| dbp:h | |
| dbp:image | - Dehydroepiandrosterone enanthate molecule ball.png (en)
|
| dbp:iupacName | - [-10,13-Dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] heptanoate (en)
|
| dbp:legalStatus | |
| dbp:metabolites | - • Others (en)
- • Prasterone (en)
|
| dbp:o | |
| dbp:pubchem | |
| dbp:routesOfAdministration | |
| dbp:smiles | - CCCCCCCO[C@H]1CC[C@@]2C (en)
|
| dbp:stdinchi | |
| dbp:stdinchikey | - HHENOUDBWKNPAB-BNCSLUSBSA-N (en)
|
| dbp:synonyms | - DHEA enanthate; Prasterone heptanoate; DHEA heptanoate; DHEA-E; EDHEA; SH-90300-D; SH-70833-D ; Androst-5-en-3β-ol-17-one 3β-heptanoate (en)
|
| dbp:title | |
| dbp:titlestyle | |
| dbp:tradename | - With estradiol valerate: Gynodian Depot, others (en)
|
| dbp:unii | |
| dbp:width | |
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type | |
| rdfs:comment | - Prasterone enanthate, also known as dehydroepiandrosterone enanthate (DHEA-E) and sold in combination with estradiol valerate under the brand name Gynodian Depot among others, is a weak androgen, estrogen, and neurosteroid medication which is used as a component of menopausal hormone therapy to treat menopausal symptoms in women. It is available only as an injectable preparation in combination with estradiol valerate. The medication is given by injection into muscle typically once every 4 weeks. (en)
|
| rdfs:label | - Prasterone enanthate (en)
|
| rdfs:seeAlso | |
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:depiction | |
| foaf:isPrimaryTopicOf | |
| isdbo:wikiPageRedirects of | |
| isdbo:wikiPageWikiLink of | |
| isdbp:caption of | |
| isrdfs:seeAlso of | |
| isfoaf:primaryTopic of | |
